Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Aurora Cannabis ( (TSE:ACB) ) has provided an announcement.
Aurora Cannabis, in collaboration with its subsidiary MedReleaf Australia, has removed the concession card requirement for its IndiMed products, allowing broader patient access to medical cannabis in Australia. This move reflects Aurora’s commitment to simplifying prescription processes and adapting quickly to market demands, enhancing its position in the growing Australian medical cannabis market.
More about Aurora Cannabis
Aurora Cannabis Inc. is a Canadian-based global leader in the medical cannabis industry, operating in nationally regulated markets. The company focuses on providing high-quality medical cannabis products and has a significant market presence through its various brands, including IndiMed.
YTD Price Performance: 47.11%
Average Trading Volume: 2,596,856
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $363.6M
Find detailed analytics on ACB stock on TipRanks’ Stock Analysis page.